Graft Polymer UK PLC
LSE:GPL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (2.8), the stock would be worth GBX0.21 (24% upside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 2.3 | GBX0.17 |
0%
|
| 3-Year Average | 2.8 | GBX0.21 |
+24%
|
| 5-Year Average | 4.5 | GBX0.33 |
+97%
|
| Industry Average | 0 | GBX0 |
-99%
|
| Country Average | 0 | GBX0 |
-99%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
G
|
Graft Polymer UK PLC
LSE:GPL
|
3.8m GBP | 2.3 | -1.4 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
80.3B USD | 17.5 | 31.3 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
13.3T JPY | 3.1 | 27.3 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
75.3B USD | 7.7 | 36.3 | |
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
10.8T JPY | 0.7 | 10.5 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
280.1B CNY | 2.6 | 21.3 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
26B CHF | 5.7 | 24.2 | |
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 11.8 | 54.8 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.4T INR | 12 | 60.9 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
24.1B USD | 3 | 15.3 | |
| US |
|
Albemarle Corp
NYSE:ALB
|
22B USD | 2.3 | -32.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0 |
| 70th Percentile | 0 |
| Max | 49 422.3 |
Other Multiples
Graft Polymer UK PLC
Glance View
Graft Polymer (UK) Ltd. is a holding company, which comprises polymer modification and drug delivery systems developments. The firm's primary business comprises polymer modification and drug delivery systems developments. The company develops range of products, including grafted polymer modifiers; nano-structured and crosslinking polymer alloys; and a variety of delivery vehicles for pharma and bio applications. Its products fall into the category of standard products, such as Polypropylene-based composites, Polyamide-based composites, and other composites; custom made products; and innovative products, such as GRAFTALLOY, GRAFTAKIT, GRAFTAMER TRC, and GRAFTAMER VTR. The firm provides three main types of modification solutions, including Graft/Block copolymers, Polymeric Nano-Structured Alloys and Crosslinking Master batches.
